BIOGEN INC. - COMMON STOCK

Update on Regulatory Review of Lecanemab for Early Alzheimer’s Disease in the European Union

26 Jul 2024 06:20:38 By Nasdaq GlobeNewswire

Biogen Completes Acquisition of Human Immunology Biosciences

02 Jul 2024 08:16:51 By Nasdaq GlobeNewswire

“LEQEMBI®” (Lecanemab) for the Treatment of Alzheimer’s Disease Launched in China

27 Jun 2024 18:39:36 By Nasdaq GlobeNewswire

TOFIDENCE™ (tocilizumab), a Biosimilar Referencing ROACTEMRA®, Approved in the European Union

24 Jun 2024 06:30:00 By Nasdaq GlobeNewswire

FDA Accepts Eisai’s Filing of LEQEMBI® (lecanemab-irmb) Supplemental Biologics License Application for IV Maintenance Dosing for the Treatment of Early Alzheimer’s Disease

09 Jun 2024 18:37:43 By Nasdaq GlobeNewswire

Biogen and Delta Flight Products to Collaborate with Advocates and Patients to Inform the Future of Accessible Air Travel

03 Jun 2024 06:30:00 By Nasdaq GlobeNewswire

Biogen Receives European Commission Approval for QALSODY® (tofersen), the First Therapy to Treat a Rare, Genetic Form of ALS

30 May 2024 15:51:04 By Nasdaq GlobeNewswire

Biogen Bolsters Late-Stage Pipeline, Expands Immunology Portfolio with Agreement to Acquire Human Immunology Biosciences

22 May 2024 06:30:00 By Nasdaq GlobeNewswire

Biogen and Ionis Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral Sclerosis

16 May 2024 06:30:14 By Nasdaq GlobeNewswire

Eisai Initiates Rolling Biologics License Application to US FDA for LEQEMBI® (lecanemab-irmb) for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer’s Disease Under the Fast Track Status

14 May 2024 18:33:37 By Nasdaq GlobeNewswire

Biogen Reports Progress on Corporate Responsibility Priorities

02 May 2024 06:30:00 By Nasdaq GlobeNewswire

Biogen Receives Positive CHMP Opinion for TOFIDENCE™ (tocilizumab), a Biosimilar Referencing ROACTEMRA®

25 Apr 2024 15:05:00 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: BIOGEN INC. - COMMON STOCK

19 Apr 2024 08:50:39 By NetDania Notify

NetDania - New 12 months Low: BIOGEN INC. - COMMON STOCK

18 Apr 2024 08:45:07 By NetDania Notify

NetDania - New 12 months Low: BIOGEN INC. - COMMON STOCK

17 Apr 2024 08:50:10 By NetDania Notify

NetDania - New 12 months Low: BIOGEN INC. - COMMON STOCK

16 Apr 2024 08:45:06 By NetDania Notify

NetDania - New 12 months Low: BIOGEN INC. - COMMON STOCK

15 Apr 2024 08:45:35 By NetDania Notify

NetDania - New 12 months Low: BIOGEN INC. - COMMON STOCK

12 Apr 2024 11:00:50 By NetDania Notify

NetDania - New 12 months Low: BIOGEN INC. - COMMON STOCK

10 Apr 2024 08:45:08 By NetDania Notify

NetDania - New 12 months Low: BIOGEN INC. - COMMON STOCK

05 Apr 2024 08:45:10 By NetDania Notify